Comparison of the Effectiveness of the Ultrasound Guided Injections in Patients With Shoulder Impingement Syndrome

Shoulder Impingement Clinical Trial

Official title:

Comparison of the Effectiveness of the Ultrasound Guided Subacromial, Acromioclavicular With Subacromial Injection and Suprascapular Nerve Block in Patients With Shoulder Impingement Syndrome ; A Randomized Controlled, Single Blind, Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05015322
• Other study ID #: BYIEAH2
• Status: Completed
• Phase: Phase 4
• Start date: January 1, 2017
• Est. completion date: January 1, 2021

Study information

• Verified date: August 2021
• Source: Bursa Yüksek Ihtisas Education and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Shoulder pain, which is the third most common cause of musculoskeletal pain, has different etiologies. Muscle, bone structures and connective tissue pathologies can cause shoulder pain. Impingement syndrome (IS), which can cover many terms such as rotator cuff disorders, tendinitis and tears, is one of the most common pathologies of shoulder pain.

Description:

The hypothesis of this study was that injection types including ACJ would increase treatment efficacy.Therefore, this study investigated the six-month follow-up results of patients undergoing SA injection and SSNB and those receiving SA and ACJ injection.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 88
• Est. completion date: January 1, 2021
• Est. primary completion date: January 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• patients aged 18-65,

• who were suffering from shoulder pain for more than three months and

• who were diagnosed with IS.

• All patients included in the study were diagnosed with IS using Shoulder Magnetic Resonance imaging.

Exclusion Criteria:

• the presence of cervical radiculopathy;

• undergoing shoulder operation before;

• the presence of central nervous system or

• the presence of rheumatological disease, and polyneuropathy;

• receiving physical therapy in the shoulder area with a diagnosis of IS within the last six months; and

• receiving any injection therapy in the past.

Related Conditions & MeSH terms

• Shoulder Impingement
• Shoulder Impingement Syndrome
• Ultrasound Guided Injection

Intervention

Drug:
• bupivacaine and methylprednisolone
5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area
• bupivacaine and methylprednisolone
5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area for the subacromial+acromioclavicular joint injection. In addition, 2 mL of 20 mg methylprednisolone and the same concentration of local anaesthetic were injected into the acromioclavicular joint
• bupivacaine and methylprednisolone
suprascapular nerve block was administered with a mixture of 10 mL of 0.25% bupivacaine and 40 mg methylprednisolone

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Bursa Yüksek Ihtisas Education and Research Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual Analogue Scale (VAS)	for pain. 0: no pain at all, 10: worst pain imaginable	six month
Secondary	Shoulder pain and disability index (SPADI)	This scale was developed to measure pain and disability associated with shoulder pain. It consists of two parts evaluating pain and disability.	six month
Secondary	Short-Form 12 (SF-12)	The SF-12 has a physical (SF12-PCS) and mental (SF12-MCS) state assessment scale	six month